Similar articles

• Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study.

  Cosgrove DM 3rd, Heric B, Lytle BW, Taylor PC, Novoa R, Golding LA, Stewart RW, McCarthy PM, Loop FD. Cosgrove DM 3rd, et al. Ann Thorac Surg. 1992 Dec;54(6):1031-6; discussion 1036-8. doi: 10.1016/0003-4975(92)90066-d. Ann Thorac Surg. 1992. PMID: 1280411 Clinical Trial.
• Alpha-2 plasmin inhibitor-plasmin complex and postoperative blood loss: double-blind study with aprotinin in reoperation for myocardial revascularization.

  Minami K, Notohamiprodjo G, Buschler H, Prohaska W, Reichelt W, Körfer R. Minami K, et al. J Thorac Cardiovasc Surg. 1993 Nov;106(5):934-6. J Thorac Cardiovasc Surg. 1993. PMID: 7694000 Clinical Trial. No abstract available.
• Is aprotinin indicated for reoperative valvular surgery?

  Goldstein DJ, DeRosa CM, Seldomridge JA, Weinberg AD, Oz MC, Smith CR. Goldstein DJ, et al. J Heart Valve Dis. 1997 Jan;6(1):88-92. J Heart Valve Dis. 1997. PMID: 9044087 Clinical Trial.
• A special article following the relicence of aprotinin injection in Europe.

  Royston D, De Hert S, van der Linden J, Ouattara A, Zacharowski K. Royston D, et al. Anaesth Crit Care Pain Med. 2017 Apr;36(2):97-102. doi: 10.1016/j.accpm.2017.02.001. Epub 2017 Feb 13. Anaesth Crit Care Pain Med. 2017. PMID: 28215980 Review. No abstract available.
• The current place of aprotinin in the management of bleeding.

  Royston D. Royston D. Anaesthesia. 2015 Jan;70 Suppl 1:46-9, e17. doi: 10.1111/anae.12907. Anaesthesia. 2015. PMID: 25440394 Review.